Medical Ethics

REVIEW

Ethical issues of the off-label use of drugs for treatment of COVID-19

Severova YaG, Teplova NV

Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Yaroslavna G. Severova
Ostrovityanov ul. 1, Moscow, 117513, Russia; moc.liamg@ves.anvalsoray

About paper

Author contribution: Severova YaG developed the concept and the structure of the article, reviewed the literature and wrote the text; Teplova NV contributed to the article concept development, provided academic supervision, finalized the text and approved it before publishing.

Received: 2022-07-25 Accepted: 2022-08-26 Published online: 2022-11-29

No data available...

Link to the next paper will be sent to the indicated e-mail's:

REVIEW Ethical issues of the off-label use of drugs for treatment of COVID-19

Severova YaG, Teplova NV

Published in "Bulletin of RSMU" 3, 2022

I want to receive a copy of this message

Vancouver style

Severova YG, Teplova NV. Ethical issues of the off-label use of drugs for treatment of COVID-19. Medical Ethics. 2022; (3): 18–20. DOI: 10.24075/medet.2022.055

Harvard style

Severova, Y. G. and Teplova, N. V. (2022), "Ethical issues of the off-label use of drugs for treatment of COVID-19", Medical Ethics, no. 3, p. 18–20. DOI: 10.24075/medet.2022.055

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2022 / 03

REVIEW

Ethical issues of the off-label use of drugs for treatment of COVID-19